Li Y - Search Results

1

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.

Song Z, Li Y, Chen S, Ying S, Xu S, Huang J, Wu D, Lv D, Bei T, Liu S, Huang X, Xie C, Wu X, Fu J, Hua F, Wang W, Xu C, Gao C, Cai S, Lu S, Zhang Y. Song Z, et al. Among authors: li y. BMC Med. 2022 Feb 1;20(1):42. doi: 10.1186/s12916-022-02245-z. BMC Med. 2022. PMID: 35101045 Free PMC article. Clinical Trial.

2

Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors.

Lin Q, Cai GP, Yang KY, Yang L, Chen CS, Li YP. Lin Q, et al. BMC Cancer. 2016 Aug 3;16:593. doi: 10.1186/s12885-016-2623-4. BMC Cancer. 2016. PMID: 27488410 Free PMC article.

3

Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.

Li Y, Xu H, Su S, Ye J, Chen J, Jin X, Lin Q, Zhang D, Ye C, Chen C. Li Y, et al. PLoS One. 2017 Aug 22;12(8):e0183331. doi: 10.1371/journal.pone.0183331. eCollection 2017. PLoS One. 2017. PMID: 28829813 Free PMC article.

4

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients.

Lin Q, Zhang H, Ding H, Qian J, Lizaso A, Lin J, Han-Zhang H, Xiang J, Li Y, Zhu H. Lin Q, et al. Among authors: li y. J Transl Med. 2019 Aug 30;17(1):298. doi: 10.1186/s12967-019-2036-7. J Transl Med. 2019. PMID: 31470866 Free PMC article.

5

Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study.

Xu Y, Huang Z, Lu H, Yu X, Li Y, Li W, Chen J, Chen M, Gong L, Chen K, Qin J, Xu X, Jin Y, Zhao J, Shi X, Han N, Xie F, Zhang P, Xu W, Fan Y. Xu Y, et al. Among authors: li y, li w. Br J Cancer. 2019 Oct;121(8):640-646. doi: 10.1038/s41416-019-0583-6. Epub 2019 Sep 16. Br J Cancer. 2019. PMID: 31523058 Free PMC article. Clinical Trial.

6

Dynamics of Plasma EGFR T790M Mutation in Advanced NSCLC: A Multicenter Study.

Yang Z, Li J, Hu Y, Chen M, Peng D, Zong D, Shang Q, Tao L, Zhao Y, Ni Y, Ye J, Xie Y, Yang L, Lin Q, Cai C, Xu N, Huang X, Dong X, Zhou Z, Yu Y, Shangguan Z, Xu Y, Ying W, Weng M, Yuan Z, Dong Z, Li J, Zheng Z, Pan J, Liu L, Ye J, Zhang Z, Li W, Zhu J, Jin S, Li Y, Ding C. Yang Z, et al. Among authors: li y, li j, li w. Target Oncol. 2019 Dec;14(6):719-728. doi: 10.1007/s11523-019-00682-0. Target Oncol. 2019. PMID: 31691892

7

Detection of plasma T790M mutation after the first generation EGFR-TKI resistance of non-small cell lung cancer in the real world.

Li H, Wang J, Zhang G, Li Y, Lin L, Yang H, Zhou J, Zhang L, Lv D. Li H, et al. Among authors: li y. J Thorac Dis. 2020 Mar;12(3):550-557. doi: 10.21037/jtd.2019.12.122. J Thorac Dis. 2020. PMID: 32274120 Free PMC article.

8

Long-term safety of icotinib in patients with non-small cell lung cancer: a retrospective, real-world study.

Zhang W, Zhang Y, Zhao Q, Liu X, Chen L, Pan H, Li Y, Lu Y, Huang J, Zhang Z, Du K, Zhang S, Li T, Lu L, Yu G, Wang Y, Yuan X, Yang M, Ma Y, Tan F. Zhang W, et al. Among authors: li t, li y. J Thorac Dis. 2020 Mar;12(3):639-650. doi: 10.21037/jtd.2019.12.115. J Thorac Dis. 2020. PMID: 32274129 Free PMC article.

9

Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study.

Zheng J, Cao H, Li Y, Rao C, Zhang T, Luo J, Lv D, Zhu Y, Zhou J, Zhou J. Zheng J, et al. Among authors: li y. Lung Cancer. 2020 Sep;147:130-136. doi: 10.1016/j.lungcan.2020.07.016. Epub 2020 Jul 16. Lung Cancer. 2020. PMID: 32702569

10

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12).

Zhou C, Wu L, Fan Y, Wang Z, Liu L, Chen G, Zhang L, Huang D, Cang S, Yang Z, Zhou J, Zhou C, Li B, Li J, Fan M, Cui J, Li Y, Zhao H, Fang J, Xue J, Hu C, Sun P, Du Y, Zhou H, Wang S, Zhang W. Zhou C, et al. Among authors: li y, li j, li b. J Thorac Oncol. 2021 Sep;16(9):1501-1511. doi: 10.1016/j.jtho.2021.04.011. Epub 2021 May 25. J Thorac Oncol. 2021. PMID: 34048947 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218,924 results

Search Page